Finishing Strong While Looking Ahead

The December installment of Pharma Commerce is upon us, and it’s special for a multitude of reasons.

It’s difficult to believe that a handful of issues have already preceded this one and that as I write this editor’s note, I’m also preparing to attend Informa’s Trade & Channel Strategies conference in Philadelphia. The annual show brings together thought leaders in the pharma space, with an emphasis on channel strategy, distribution efforts, pharma model integration, and the development of trade.

Meanwhile, over the past few months, the day-to-day at Pharmaceutical Commerce has been nothing short of action-packed. For one, I’ve personally been on a mission to add an extra dose of innovation to the brand by creating what have essentially become weekly LinkedIn vertical videos based on happenings at the publication. Whether that be new issue promos—including an endorsement from MJH Life Sciences Chairman and CEO Mike Hennessy Jr. himself—moderating opportunities, or even the fact that our magazine ships worldwide.

It’s all about finishing the year strong, with momentum heading into the New Year.

To that end, we also recently unveiled our 2026 editorial calendar, which is as expansive as it’s ever been. Some highlights in store for the first half of the year include:

• A pharma third-party logistics provider roundtable in February featuring trends and strategies in the space, a tradition of the brand over the past few years.
• Our signature cold chain landscape feature in April that revisits the sector, including new go-to technologies.
• Content in June on how to successfully leverage real-world data to optimize post-market performance and patient outcomes.

Of course, this only represents a microcosm of what we’ve got in store, so be sure to stay tuned for monthly developments.

Until then, all of us here wish you a marvelous end to the year and a game-changing 2026.

— Nicholas Saraceno is Pharmaceutical Commerce's Editor. He can be reached at [email protected].